Cardiff Oncology (FRA:XE7C) Shares Buyback Ratio % : -0.07 (As of May. 25, 2024)

View and export this data going back to 1997. Start your Free Trial

What is Cardiff Oncology Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Cardiff Oncology's current shares buyback ratio was -0.07%.

Cardiff Oncology Shares Buyback Ratio % Historical Data

The historical data trend for Cardiff Oncology's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiff Oncology Shares Buyback Ratio % Chart

Cardiff Oncology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-124.27

-328.00

-14.09

-6.47

Cardiff Oncology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	-	-	-	-0.07

Cardiff Oncology Shares Buyback Ratio % Calculation

Cardiff Oncology's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2022 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	(44.677	-	44.677)	/	44.677
	=	0.00%

Cardiff Oncology's Shares Buyback Ratio for the quarter that ended in Mar. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Mar. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(44.677	-	44.71)	/	44.677
	=	-0.07%

Cardiff Oncology Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Cardiff Oncology's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardiff Oncology (FRA:XE7C) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardiff Oncology Inc (FRA:XE7C) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

CRDF:USA

Address

11055 Flintkote Avenue, San Diego, CA, USA, 92121

Website

https://www.cardiffoncology.com

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.

Cardiff Oncology (FRA:XE7C) Headlines

No Headlines